Treat depression like an expert psychiatrist. The definitive point of care app with the latest recommendations for outpatient depression medication management.

Designed by expert psychiatrists from Columbia University and delivered via cutting edge, interactive technology from avoMD, this evidence-based app provides a practical, easy-to-use treatment algorithm for major depression.

The app incorporates Columbia’s Accelerated Sequential Antidepressant Protocol (ASAP) © 2021 The Trustees of Columbia University in the City of New York. Complete with calculators to assess depression severity (PHQ-9 and Columbia Depression Scale), bipolar screening, and suicide risk assessment, this app puts all the information needed to treat depression at your fingertips. Also included are clinical pearls, such as how to titrate antidepressants and manage common side effects.

A revamp of the STAR*D Trial published in 2006, ASAP recommends rapid titrations and follow up with a focus on the 7 best-tolerated generic antidepressants, providing a quicker and easier way to treat depression.
Columbia Psychiatry Pathways is intended for use in outpatient settings by psychiatrists, primary care physicians, NPs, PAs, med students, residents, and trainees as they treat patients with depression.

FEATURES:
• Designed by experts from Columbia’s Department of Psychiatry and delivered via avoMD’s next gen decision support technology
• Regularly updated to reflect the latest research, with external links to the evidence
• Provides clinical pearls for depression treatment, including a walkthrough of titration recommendations, management of common side effects, and more
• Covers the 7 essential meds you need to know to effectively treat outpatient depression
• Includes recommendations on managing DSM-5 depression and screening for bipolar disorder and suicide risk
• Measure symptom severity using built-in calculators for Patient Health Questionnaire-9 item (PHQ-9) and the Columbia Depression Scale
• Intended for outpatient settings to aid psychiatrists, primary care physicians, nurse practitioners, physician assistants, and trainees make real-time psychopharmacologic decisions
• Functions as a teaching and learning tool for program directors, residents, med students, and other trainees

Institutional subscriptions include access to mobile and desktop versions along with other features. For more information, please contact psychpathways@cumc.columbia.edu

Ranked #3 in NIH funding and in the top 5 psychiatry hospitals in the country by US News, the Department of Psychiatry at Columbia University has been a preeminent academic psychiatry department for over 100 years. Columbia Psychiatry faculty have led the development of the Diagnostic and Statistical Manual of Mental Disorders (DSM) and served as leaders in the field including the current National Institutes of Mental Health Director. The inventors of this clinical algorithm are J. John Mann, MD, co-director of Columbia’s Center for the Prevention and Treatment of depression and a leading researcher in the field of mood disorders, and Ravi N. Shah, MD, MBA, a pioneer in digital mental health and the department’s Chief Innovation Officer.

avoMD transforms clinical guidelines, pathways, and algorithms into interactive, next-gen decision support apps, made available as standalone mobile and web apps and via EHR integrations. Leading academic medical centers, urgent cares, and trainee programs are using avoMD to digitize their clinical content and put them in the hands of their providers or distribute them externally. In randomized control trials and usability studies, the software has been shown to save providers time while improving clinical accuracy. Current investors and supporters include Columbia University’s Lang Entrepreneurship Center, Mount Sinai Innovation Partners’ Elementa Labs, StartUp Health, and 500 Startups. The team is led by physicians and informaticians from Columbia, Harvard, and Yale.